Who are AIQ's investors?

AIQ's investors include Aurora Forge, Capital Midwest Fund, New York Angels, Rock River Capital Partners, Tundra Angels, Venture Management.

How much funding has AIQ raised?

AIQ has disclosed $1.5M raised across 1 round.

Where is AIQ headquartered?

AIQ is headquartered in New York, US.

AIQ

New York, US · Founded 2010 · 6 known investors

Find your way into AIQ

Paths you didn't know you had: your email and LinkedIn already hold routes to the AIQ team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.

AI & Machine Learning Healthtech Medical Devices

Founders & leadership

T. Gary LibermanChief Financial Officer and Secretary

Nicholas W. StullerChief Executive Officer

Board

William O'ConorMember of the Board of Directors

Investors · 6

Aurora Forgelisted by Aurora ForgeJacksonville

Capital Midwest Fundlisted by Capital Midwest FundMequon

How we know: Capital Midwest Fund's portfolio page · Not right? Tell us

New York Angelslisted by New York AngelsNew York · $100K – $1.5M

How we know: New York Angels's portfolio page · the VCSheet dataset · Not right? Tell us

Rock River Capital Partnerslisted by Rock River Capital PartnersMadison · $500K – $1M

Tundra Angelslisted by Tundra AngelsGreen Bay · $100K – $500K

Venture Managementlisted by Venture ManagementMadison

How we know: Venture Management's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 1 round · 2014

▶$1.5MraisedApr 2014 · 13 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

William O'ConorDirector
T. Gary LibermanExecutive Officer
Nicholas W. StullerExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $1.5M
First sale: Mar 2014
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2023	$881.6K
National Institutes of Health (NIH)National Institutes of Health	Phase II	2022	$2M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2020	$388.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does AIQ do?: AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.
Who are AIQ's investors?: AIQ's investors include Aurora Forge, Capital Midwest Fund, New York Angels, Rock River Capital Partners, Tundra Angels, Venture Management.
How much funding has AIQ raised?: AIQ has disclosed $1.5M raised across 1 round.
Where is AIQ headquartered?: AIQ is headquartered in New York, US.